Nkarta
Price & Volume
Stats
See more52W Range | $1.70-$3.72 |
Market Cap | $188.3M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $385 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$36.2M |
Diluted EPS | -$1.59 |
News
See moreYahoo Finance • 18 days ago
Nkarta Posts Wider Loss In Q2; Provides Clinical Update On NKX019
Yahoo Finance • last month
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
Yahoo Finance • 2 months ago
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Yahoo Finance • 4 months ago
Nkarta GAAP EPS of -$0.37 in-line
About
CEO | Mr. Paul J. Hastings |
Address | 1150 Veterans Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 106 |